Recent Updates
Recently added Catalysts
Join 12,400+ Investors who are already making profits

Most actionable catalysts events
for Biotech and Pharma investors

Simplifying biotech and pharma investing with real-time insights from scientists and investment experts. We track over 1100 companies and 85+ metrics like

FDA Calendar
Start Free Trial

Upcoming Catalysts That Could Move The Market

Explore All
BioLineRx Ltd.
$1.35 -0.14 (-9.40%)
Catalyst Date13-11-2026
Pre-clinical
10%
Expected move±80%
ConvictionMedium
30d move-31%
2 funds accumulating
Probability Of Approval7.5%

GLIX1 is BioLineRx’s first-in-class oral small molecule, developed in… (Read More)

Zai Lab Limited
$26.04 -0.38 (-1.44%)
Catalyst Date13-11-2026
Phase 1/1b
0%
Expected move±19%
ConvictionLow
30d move+14%
4 funds accumulating29mo runway well funded
Probability Of Approval12%

ZL-1503 is an internally developed bispecific antibody by Zai Lab, targeting… (Read More)

$0.77 -0.03 (-3.81%)
Catalyst Date13-11-2026
Phase 1
20%
Expected move±9%
ConvictionHigh
30d move-54%
1mo runway dilution risk
Probability Of Approval12%

REYOBIQ, also known as rhenium Re-186 obisbemeda or \(^{186}\)RNL, is an… (Read More)

Intellia Therapeutics, Inc.
$10.55 -0.86 (-7.54%)
Orphan DrugPriority Review+1
Catalyst Date13-11-2026
Phase 1/2
20%
Expected move±38%
ConvictionLow
30d move-4%
5 funds accumulating21mo runway well funded
Probability Of Approval90%

Lonvoguran ziclumeran, or lonvo-z (NTLA-2002), is an investigational one-time… (Read More)

$1.19 -0.07 (-5.56%)
Catalyst Date13-11-2026
Phase 2
40%
Expected move±9%
ConvictionMedium
30d move+5%
4 insiders buying1 fund accumulating8mo runway dilution risk
Probability Of Approval12%

Bezisterim, also known as NE3107, is an orally administered small-molecule… (Read More)

NeOnc Technologies Holdings, Inc.
$4.85 0.33 (7.30%)
Fast Track
Catalyst Date13-11-2026
Phase 1
20%
Expected move±9%
ConvictionMedium
30d move+74%
3 insiders buying3mo runway dilution risk
Probability Of Approval8%

NEO212 is an investigational oral chemical conjugate developed by NeOnc… (Read More)

Gain Therapeutics, Inc.
$1.08 -0.03 (-2.70%)
Catalyst Date13-11-2026
Phase 1b
20%
Expected move±38%
ConvictionMedium
30d move-21%
11mo runway
Probability Of Approval12%

Rexaceract, also known as GT-02287, is an orally administered, brain-penetrant… (Read More)

Pasithea Therapeutics Corp.
$0.52 -0.01 (-2.27%)
Fast TrackOrphan Drug+1
Catalyst Date13-11-2026
Phase 1/1b
0%
Expected move±9%
ConvictionMedium
30d move+26%
2 funds accumulating26mo runway well funded
Probability Of Approval17.5%

PAS-004 is a next-generation macrocyclic MEK inhibitor developed by Pasithea… (Read More)

Rhythm Pharmaceuticals, Inc.
$109.86 -2.30 (-2.05%)
Orphan DrugBreakthrough Therapy+1
Catalyst Date14-11-2026
Phase 3
60%
Expected move±8%
ConvictionLow
30d move+30%
10 funds trimming60mo runway well funded
Probability Of Approval99%

IMCIVREE (setmelanotide), developed by Rhythm Pharmaceuticals (RYTM), is a daily… (Read More)

$33.83 -0.35 (-1.02%)
Orphan Drug
Catalyst Date14-11-2026
Phase 3
60%
Probability Of Approval82%

Deucrictibant XR 40 mg is Pharvaris N.V.’s innovative once-daily… (Read More)

$13.90 0.01 (0.07%)
Catalyst Date14-11-2026
Phase 3
60%
Probability Of Approval99%

VTAMA, or tapinarof cream 1%, is a nonsteroidal topical therapy developed by… (Read More)

MBX Biosciences, Inc.
$54.51 -3.21 (-5.56%)
Catalyst Date14-11-2026
Pre-clinical
10%
Expected move±42%
ConvictionLow
30d move+18%
14 funds accumulating41mo runway well funded
Probability Of Approval3%

MBX 6180 is a preclinical candidate developed by MBX Biosciences, targeting… (Read More)

Trusted by Industry Leaders: Providing top tier bio/pharma equity research.

Our partners include leading names across life sciences, clinical research, and institutional investing.

BMO logo
ladenburg thalmann logo
jp morgan logo
schroders logo
CTI logo
jefferies logo
genentech logo
astrazeneca logo
bayer logo
sanofi ventures logo
mirae asset logo
iqvia logo

Your key to successful investing

Our comprehensive screening and analysis tools

FDA Calendar - track upcoming drug approval dates
FDA  Calendar

Don’t miss a beat: Click here for real time updates on upcoming catalysts with our FDA calendar

CatalystSync - biotech catalyst watchlist and alerts
CatalystSync™

CatalystSync™ is an integrated platform that provides a complete overview of clinical trials in CatalystSync.

Biotech company screener - filter by phase, market cap and more
1000+ Companies Screener

Discover popular biotech investing themes and create your own Screener.

Biotech earnings calendar - upcoming earnings dates and reports
Biotech Earning Calendar

Stay ahead of the earnings game with our Biotech Earnings Calendar.

Insider trading tracker - CEO and executive stock transactions
Inside Trading

Access our Insider Trades tool for the latest trades by top executives and insiders.

Biotech hedge fund tracker - institutional holdings and 13F filings
Biotech and Pharma Hedge Funds

Follow the smart money with our hedge fund tracking, understanding the moves and strategies of key players in the industry.

CatalystSync™
CatalystSync™

CatalystSync™ is an integrated platform that provides a complete overview of clinical trials in CatalystSync.

Check Now
FDA Calendar
FDA Calendar

Don’t miss a beat: Click here for real-time updates on upcoming catalysts with our FDA calendar

Check Now
Biotech Earning Calendar
Biotech Earning Calendar

Stay ahead of the earnings game with our Biotech Earnings Calendar.

Check Now
Inside Trading
Inside Trading

Access our Insider Trades tool for the latest trades by top executives and insiders.

Check Now
1000+ Companies Screener
1000+ Companies Screener

Discover popular biotech investing themes and create your own Screener.

Check Now
Biotech and Pharma Hedge Funds
Biotech and Pharma Hedge Funds

Follow the smart money with our hedge fund tracking, understanding the moves and strategies of key players in the industry.

Check Now

Turn Biotech Events Into Clear Decisions

BiopharmaWatch brings clinical catalysts and market data into one view. Monitor 1,100+ companies with 85+ metrics, including FDA/PDUFA calendar, trial progress, financial signals and much more.

Catalyst Calendars: FDA/PDUFA, trial readouts, conferences, earnings, IPOs

Company and Drug Intel: pipeline, indication, phase, timelines, history

Options Flow: unusual activity and positioning around catalysts

Smart Money: hedge fund holdings and insider trades

BPW Model Portfolios: 2 model portfolios built from the 13F filings of 45 specialist biotech hedge funds

Screeners + Alerts: filter fast, track watchlists, get notified when things change

Start Free Trial
slider imageslider imageslider imageslider imageslider imageslider image

Getting Started

Our comprehensive screening and analysis tools ‍

01
New Investors

Embark on your biotech investing journey with confidence. BiopharmaWatch helps you understand key concepts like clinical trials, FDA milestones, and pipelines, while our FDA and earnings calendars highlight the events that really move stocks. Learn faster and avoid beginner mistakes from day one.

02
Active & Expert Investors

Level up your edge with professional-grade data. Screen hundreds of biotech and pharma names by catalysts, market cap, hedge fund activity, and insider trades. Combine event timelines with price action so you can position before the crowd, manage risk, and refine your strategy over time.

03
Analysts, Advisors & Funds

Turn complex biotech stories into clear, actionable insights for your clients and team. Track upcoming data readouts and regulatory decisions in one place, export structured reports, and use our tools to back your recommendations with transparent, data driven evidence.

API Access

Simple Pricing, Powerful Insights

Full access to Biotech/Pharma investing and trading opportunities.

No hidden fees, powerful insights, tools, and exclusive real-time data to maximize your biotech profits.

yearly_arrow
Recommended
Elite Plus
For Serious Investors and Traders

Your Key to Consistent Profits: Save Big with Our Annual Plan at Just $29.00 per Month

Only $29.00/ Month

  • BiopharmaWatch AI analysis on every company page, updated when news breaks
  • 200 AI credits a month (1,000 a month on the annual plan) for custom research reports on any company, catalyst, or disease you choose
  • Alerts within minutes on your tickers: press releases, SEC filings, and catalyst date changes
  • Expected move into each catalyst, where the stock has listed options
  • All years of FDA history, pipeline value, every hedge fund quarter, and 3,000 download credits a month
  • Searchable FDA Calendar with 1,000+ catalysts like clinical readouts and PDUFA
  • Full access to drug pipelines and company health for informed decisions
  • Probability of Approval (PoA) scorecards for each asset
  • Download all data in Excel for your models
  • Historical FDA decisions to shape strategic plans
  • Track biotech earnings and critical catalyst events
  • Monitor insider trading and hedge fund holdings for market insights
  • Options flow and strategy modules (screeners and playbooks)
  • Advanced portfolio tools for smart biotech investments
  • Research on 1,100+ companies and clinical trials
  • Real-time market updates, trends, and analysis
  • Live news feed with customizable alerts (tickers, drugs, indications)
  • Exclusive courses on biotech investment basics
Elite
For Explorers

Explore every biotech catalyst and discover why serious investors and traders choose Elite Plus.

Only $24.00/ Month

  • 1,000 AI credits a month on the annual plan; unused credits roll over until it renews
  • Searchable FDA Calendar with 1,000+ catalysts like clinical readouts and PDUFA
  • Full access to drug pipelines and company health for informed decisions
  • Probability of Approval (PoA) scorecards for each asset
  • Download all data in Excel for your models
  • Historical FDA decisions to shape strategic plans
  • Track biotech earnings and critical catalyst events
  • Monitor insider trading and hedge fund holdings for market insights
  • Options flow and strategy modules (screeners and playbooks)
  • Advanced portfolio tools for smart biotech investments
  • Research on 1,100+ companies and clinical trials
  • Real-time market updates, trends, and analysis
  • Live news feed with customizable alerts (tickers, drugs, indications)
  • Exclusive courses on biotech investment basics
  • 300 download credits a month and the last 2 years of FDA history
See Why Professionals Choose BiopharmaWatch
Join 12,400+ Investors who are already making profits

Since using BiopharmaWatch, my trades tied to biotech events have been 30% more successful. The FDA Calendar is like my secret weapon for timing the market always detailed and up-to date!

My portfolio is up 23% since I started using the Company Screener. It’s so easy to spot strong companies and avoid cash-burn disasters with the clear financial metrics provided!

Integrating the API has improved our trading models by 25% with real time data on 200+ catalysts. It’s fast, accurate, and has saved us countless hours of manual work!

CatalystSync™ saves me hours weekly, tracking 50+ trials for my R&D projects. It’s intuitive, efficient, and has helped uncover trends I might have missed otherwise!

We’ve already found three partnership opportunities this quarter thanks to CatalystSync™. The pipeline insights and market cap data give us a huge competitive edge!

Using BiopharmaWatch, we’ve identified two companies with 40%+ returns this year. The PDUFA Calendar alone justifies the subscription-it’s incredibly detailed and actionable!

The portfolio tracking tools make managing my biotech investments so much smoother. Tracking catalysts and pipelines has helped me make better decisions that really pay off!

The Hedge Fund Screener helped us align with top performing funds, boosting our portfolio by 15%. It’s like having insider knowledge of how major players shape their biotech strategies!

Thanks to the searchable FDA Calendar and PDUFA catalysts, I’ve capitalized on key market moving events. This platform has been crucial for generating steady profits!

The research on over 1,100 companies and clinical trials is simply impressive. It’s helped shape more informed, strategic plans for both my investments and R&D work!

The FDA Calendar lists upcoming biotech catalysts, including clinical readouts (preclinical through Phase 3), PDUFA decisions, top-line results, advisory committee dates, and key regulatory milestones. You can filter by therapeutic area, disease, stage, and timing, and set alerts so you never miss a window.

Yes. The dedicated PDUFA calendar shows upcoming FDA approval dates, changes, and outcomes. Elite Plus includes full historical PDUFA data with run-up and run-down analytics so you can study how price typically moves into and after decisions.

Catalyst data is manually updated twice daily, while the rest of the data, including real-time financials and market trends, is updated continuously throughout the day.

We use company press releases, SEC filings, clinical registries, investor decks, scientific publications, and conference posters and schedules. Each item is standardized so you can compare across companies.

PoA scorecards estimate the likelihood of approval using indication-specific base rates, trial design, and historical outcomes. Use PoA to compare risk-reward across assets and align position size to probability.

Yes. Elite and Elite Plus include Excel exports for FDA and PDUFA catalysts, company and pipeline profiles, conference schedules, insider trades, and other datasets to feed your models.

Yes. The API provides programmatic access to FDA events, PoA, historical catalysts, insider and hedge fund data, pipelines, and much more.

Yes, you can cancel anytime through your ‘My Subscription’ page. Simply click your profile picture in the top right menu. You can also reach out to us at contact@biopharmawatch.com for assistance.

Free is a preview only. Elite and Elite Plus unlock full coverage, alerts, PoA, options, exports, and more. Annual billing saves up to 26% and includes a quarterly 30-minute strategy call.
FAQ
Still Have Questions?

Can't find the answer you're looking for? Please chat to our friendly team.